Indian pharmaceutical stocks faced a setback after Donald Trump’s warning about potential tariffs on pharmaceutical imports. The Nifty Pharma index dropped by 1.7%, with industry giants such as Gland Pharma and Sun Pharma witnessing notable decreases in their stock values. Trump’s remarks emphasized the push to encourage pharmaceutical firms to relocate their manufacturing operations to the United States by imposing tariffs, which could have a substantial impact on India’s extensive exports of generic drugs to the US.